Recent advances and novel treatments for sphingolipidoses.

about

Recent advances and novel treatments for sphingolipidoses.

Item

http://www.wikidata.org/entity/Q38635135

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Recent advances and novel treatments for sphingolipidoses.

@en

type

Item

label

Recent advances and novel treatments for sphingolipidoses.

@en

prefLabel

Recent advances and novel treatments for sphingolipidoses.

@en

P1476

Recent advances and novel treatments for sphingolipidoses.

@en

P2093

Christoph Arenz

http://www.w3.org/2001/XMLSchema#string

P2860

Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders

Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease

Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability

Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants

Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects

Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease

Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease

Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation.

P304

1687-1700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0065

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Arenz

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28857617

http://www.w3.org/2001/XMLSchema#string

Recent advances and novel treatments for sphingolipidoses.

about

Recent advances and novel treatments for sphingolipidoses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698